PL2855475T3 - Alfa-karboliny do leczenia nowotworu - Google Patents
Alfa-karboliny do leczenia nowotworuInfo
- Publication number
- PL2855475T3 PL2855475T3 PL13726442T PL13726442T PL2855475T3 PL 2855475 T3 PL2855475 T3 PL 2855475T3 PL 13726442 T PL13726442 T PL 13726442T PL 13726442 T PL13726442 T PL 13726442T PL 2855475 T3 PL2855475 T3 PL 2855475T3
- Authority
- PL
- Poland
- Prior art keywords
- carbolines
- cancer
- alpha
- treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20120167755 EP2662372A1 (en) | 2012-05-11 | 2012-05-11 | Alpha-carbolines for the treatment of cancer |
| EP13726442.0A EP2855475B1 (en) | 2012-05-11 | 2013-05-10 | Alpha-carbolines for the treatment of cancer |
| PCT/EP2013/059721 WO2013167730A1 (en) | 2012-05-11 | 2013-05-10 | Alpha-carbolines for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2855475T3 true PL2855475T3 (pl) | 2018-02-28 |
Family
ID=48570067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13726442T PL2855475T3 (pl) | 2012-05-11 | 2013-05-10 | Alfa-karboliny do leczenia nowotworu |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9428500B2 (pl) |
| EP (2) | EP2662372A1 (pl) |
| CN (1) | CN104540823B (pl) |
| CA (1) | CA2872948A1 (pl) |
| ES (1) | ES2641816T3 (pl) |
| PL (1) | PL2855475T3 (pl) |
| WO (1) | WO2013167730A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102013010603A1 (de) * | 2013-06-26 | 2014-12-31 | Martin-Luther-Universität Halle-Wittenberg, Körperschaft des öffentlichen Rechts | Brustkrebszellwachstum-hemmende Enzyminhibitoren, Verfahren zu ihrer Herstellung sowie deren Verwendung |
| WO2019016071A1 (en) | 2017-07-18 | 2019-01-24 | Bayer Pharma Aktiengesellschaft | SUBSTITUTED PYRROLOPYRIDINE DERIVATIVES |
| CN112574176B (zh) * | 2019-09-27 | 2024-03-15 | 隆泰申医药科技(南京)有限公司 | 一种杂芳基类化合物及其应用 |
| WO2021119834A1 (en) * | 2019-12-18 | 2021-06-24 | Universite De Montreal | Modulators of cullin 3 adaptor kbtbd4 as anti-cancer compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2876377B1 (fr) * | 2004-10-11 | 2007-03-16 | Univ Claude Bernard Lyon | Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes |
| CA2610347A1 (en) * | 2005-06-09 | 2006-06-08 | Boehringer Ingelheim International Gmbh | Alpha-carbolines as cdk-1 inhibitors |
| EP2161271A1 (en) | 2008-09-08 | 2010-03-10 | Università Degli Studi Di Milano - Bicocca | Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl |
-
2012
- 2012-05-11 EP EP20120167755 patent/EP2662372A1/en not_active Withdrawn
-
2013
- 2013-05-10 ES ES13726442.0T patent/ES2641816T3/es active Active
- 2013-05-10 WO PCT/EP2013/059721 patent/WO2013167730A1/en not_active Ceased
- 2013-05-10 CN CN201380024132.1A patent/CN104540823B/zh not_active Expired - Fee Related
- 2013-05-10 CA CA 2872948 patent/CA2872948A1/en not_active Abandoned
- 2013-05-10 EP EP13726442.0A patent/EP2855475B1/en not_active Not-in-force
- 2013-05-10 US US14/399,925 patent/US9428500B2/en not_active Expired - Fee Related
- 2013-05-10 PL PL13726442T patent/PL2855475T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2872948A1 (en) | 2013-11-14 |
| US20150105554A1 (en) | 2015-04-16 |
| US9428500B2 (en) | 2016-08-30 |
| EP2855475A1 (en) | 2015-04-08 |
| WO2013167730A1 (en) | 2013-11-14 |
| ES2641816T3 (es) | 2017-11-14 |
| CN104540823A (zh) | 2015-04-22 |
| CN104540823B (zh) | 2017-02-22 |
| EP2855475B1 (en) | 2017-06-28 |
| EP2662372A1 (en) | 2013-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267242B (en) | Cancer treatment | |
| PL3967315T3 (pl) | Akkermansia muciniphila do leczenia nowotworu złośliwego | |
| IL235726A0 (en) | Pyrimidine compounds for cancer treatment | |
| PT2804599T (pt) | Terapêutica de associação para o tratamento de cancro | |
| IL263781A (en) | Combined treatment of ovarian cancer | |
| EP2903644A4 (en) | TREATMENT OF CANCER | |
| GB201217892D0 (en) | Treatment of cancer | |
| SI2892925T1 (sl) | Kombinacijsko zdravljenje raka | |
| PL2855475T3 (pl) | Alfa-karboliny do leczenia nowotworu | |
| DK2872176T3 (en) | Cancer treatment | |
| EP2934500A4 (en) | COMBINATION THERAPY AGAINST CANCER | |
| GB2519004B (en) | Quinone compounds and their uses for the treatment of cancer | |
| GB201217890D0 (en) | Treatment of cancer | |
| GB201222563D0 (en) | Cancer treatment | |
| PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
| IL237229A0 (en) | Methods of treating cancer using lipoplatin | |
| GB201222949D0 (en) | Combination Treatment of Cancer | |
| GB201222950D0 (en) | Combination treatment of cancer | |
| IL233495A0 (en) | Combination for cancer treatment | |
| GB201208296D0 (en) | Treatment of cancer | |
| IL239231A0 (en) | Combined cancer treatment | |
| AP2015008905A0 (en) | Novel compounds for the treatment of cancer |